Results 191 to 200 of about 1,666,845 (324)

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

MODOMICS: a database of RNA modifications and related information. 2025 update and 20th anniversary. [PDF]

Nucleic Acids Res
Sordyl D, Boileau E, Bernat A, Maiti S, Mukherjee S, Moafinejad SN, Farsani MA, Shavina A, Cappannini A, Agostini G, Conticello SG, Stefaniak F, Dieterich C, Purta E, Bujnicki JM.   +14 more
europepmc   +1 more source

Curation [PDF]

, 2020
openaire   +1 more source

Immune‐Driven Expression in Inclusion Body Myositis With T‐Cell Large Granular Lymphocytic Leukemia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives T‐cell large granular lymphocytic leukemia (T‐LGLL), reported in up to 58% of inclusion body myositis (IBM) patients, is a rare leukemia of cytotoxic or less commonly helper T cells. The range of myopathies in T‐LGLL and the impact of coexisting T‐LGLL in IBM are not well understood. Our objectives are to investigate the spectrum of
Pannathat Soontrapa, Iago Pinal‐Fernandez, Pritikanta Paul, Michael P. Skolka, Margherita Milone, Min Shi, Mithun V. Shah, Maria Casal‐Dominguez, Katherine Pak, Andrew L. Mammen, Teerin Liewluck   +10 more
wiley   +1 more source

Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resource. [PDF]

Front Immunol
Isbell MG, Wendling A, Pei X, Kumar A, Mannangatti P, Krisanits BA, Cheatham S, Michenkova M, Shumilov K, Mendoza RG, Fernandez ME, Bryan A, Nguyen TA, May L, Das SK, Findlay VJ, Akbarali HI, Garcia-Bonilla M, Limbrick DD, Sweet DH, da Rocha SRP, Neuwelt A, Fisher PB, Sarkar D, Wang XY, Landry JW, Martin RK.   +26 more
europepmc   +1 more source

GenBank2PubMed: Bridging Viral Genomic Data and the Scientific Literature with AI-Assisted Curation [PDF]

Kaiming Tao, Jinru Zhou, Yimam Getaneh, Robert W. Shafer   +3 more
openalex   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

Artificial intelligence for personalized management of vestibular schwannoma: a multidisciplinary clinical implementation study. [PDF]

JAMIA Open
Wijethilake N, Connor S, Oviedova A, Ivory M, Burger R, De Leon De Sagun J, Hitchings A, Abougamil A, Giannis T, Syrris C, Chia K, Al-Salihi O, Obholzer R, Jiang D, Maratos E, Barazi S, Thomas N, Vercauteren T, Shapey J.   +18 more
europepmc   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source

The DO-KB knowledgebase 2026 update: expanding programmatic and language access. [PDF]

Nucleic Acids Res
Baron JA, Johnson CMS, Schor MA, Olley D, Nickel L, Felix V, Bello SM, Greene C, Lichenstein R, Bisordi K, Koka R, Bearer C, Macatangay R, Ada N, Ballenger K, Bliss E, Colliver L, Dobbins G, Heitzig H, Dixon S, Semesky P, Garth J, Fairchild M, Gaskin P, Zahid S, Castillo R, Edwards S, Widjaja A, Usui Y, Lynch E, Clarkson M, Detwiler T, Schriml LM.   +32 more
europepmc   +1 more source